Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
Clinical trial NCT01145209 · COMPLETED
Trial details
- NCT number
- NCT01145209
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2017-10-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.